XPH Among Health Care ETFs
End-of-day Nov 20, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −7.0% | −3.3% | −14.4% | +11.3% | +19.7% | +75.7% | +30.4% | +64.9% | +402.4% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$46 of every $1,000 in XPH is Xeris
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XERSXeris Biopharma | Healthcare | 4.63% | $463.34 | 1.4M | $23.2M |
| 2 | MANEVeradermics | Healthcare | 2.68% | $268.25 | 109K | $13.4M |
| 3 | AMRXAmneal Pharmaceuticals | Healthcare | 2.67% | $266.53 | 628K | $13.4M |
| 4 | VTRSViatris | Healthcare | 2.59% | $258.98 | 657K | $13.0M |
| 5 | LLYELI Lilly + | Healthcare | 2.58% | $258.33 | 9,639 | $12.9M |
| 6 | MAZEMAZE Therapeutics | Healthcare | 2.52% | $252.33 | 392K | $12.6M |
| 7 | PRGOPerrigo | Healthcare | 2.40% | $240.43 | 756K | $12.0M |
| 8 | RPRXRoyalty Pharma | Healthcare | 2.40% | $240.24 | 179K | $12.0M |
| 9 | ELANElanco Animal Health | Healthcare | 2.40% | $239.95 | 460K | $12.0M |
| 10 | ZTSZoetis | Healthcare | 2.37% | $236.88 | 148K | $11.9M |
| 11 | COLLCollegium Pharmaceutical | Healthcare | 2.27% | $226.55 | 453K | $11.3M |
| 12 | ETONETON Pharmaceuticals | Healthcare | 2.24% | $224.19 | 184K | $11.2M |
| 13 | PBHPrestige Consumer Healthcare | Healthcare | 2.19% | $218.92 | 223K | $11.0M |
| 14 | OGNOrganon + | Healthcare | 2.19% | $218.72 | 793K | $11.0M |
| 15 | JNJJohnson + Johnson | Healthcare | 2.15% | $214.99 | 41K | $10.8M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XERS | Xeris Biopharma | 4.63% |
| 2 | MANE | Veradermics | 2.68% |
| 3 | AMRX | Amneal Pharmaceuticals | 2.67% |
| 4 | VTRS | Viatris | 2.59% |
| 5 | LLY | ELI Lilly + | 2.58% |
| 6 | MAZE | MAZE Therapeutics | 2.52% |
| 7 | PRGO | Perrigo | 2.40% |
| 8 | RPRX | Royalty Pharma | 2.40% |
| 9 | ELAN | Elanco Animal Health | 2.40% |
| 10 | ZTS | Zoetis | 2.37% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.0416 |
| Jun 22, 2026 | Jun 24, 2026 | $0.0590 |
| Mar 23, 2026 | Mar 25, 2026 | $0.0610 |
| Dec 22, 2025 | Dec 24, 2025 | $0.11 |
| Sep 22, 2025 | Sep 24, 2025 | $0.10 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0959 |
| Mar 24, 2025 | Mar 26, 2025 | $0.15 |
| Dec 23, 2024 | Dec 26, 2024 | $0.15 |
| Sep 23, 2024 | Sep 25, 2024 | $0.19 |
| Jun 24, 2024 | Jun 26, 2024 | $0.16 |
| Mar 18, 2024 | Mar 21, 2024 | $0.17 |
| Dec 18, 2023 | Dec 21, 2023 | $0.17 |